[1] Woo KT, Choong HL, Wong KS, et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases[J]. Kidney Int, 2012, 81(10):1044-1045. [2] Nugent RA, Fathima SF, Feigl AB, et al. The burden of chronic kidney disease on developing nations:a 21st century challenge in global health[J]. Nephron Clin Pract, 2011, 118(3):c269-277. [3] Farris AB, Colvin RB. Renal interstitial fibrosis:mechanisms and evaluation[J]. Curr Opin Nephrol Hypertens, 2012, 21(3):289-300. [4] Mahdavi-Mazdeh M, Hatmi ZN, Shahpari-Niri S. Does a medical management program for CKD patients postpone renal replacement therapy and mortality? A 5-year-cohort study[J]. BMC Nephrol, 2012, 13:138. [5] 林成成, 陆红, 梁勇, 等. 肾小管上皮细胞表型转化在大鼠输尿管梗阻及再通中的意义[J]. 中国应用生理学杂志, 2013, 29(5):454-456. [6] Wang QL, Tao YY, Yuan JL, et al. Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro[J]. BMC Cell Biol, 2010, 11(31):1668-1681. [7] Fan DM, Qi PW, Gao SG, et al. TGF-β1 mediates estrogen receptor-induced epithelial-to-mesenchymal transition in some tumor lines[J]. Tumour Biol, 2014, 35(11):11277-11282. [8] Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J]. Nature, 2007, 449(7163):682-688. [9] Korpal M, Lee ES, Hu G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2[J]. J Biol Chem, 2008, 283(22):14910-14914. [10] Li Y, Vanden Boom TG 2nd, Kong D, et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells[J]. Cancer Res, 2009, 69(16):6704-6712. [11] Wang JY, Gao YB, Zhang N, et al. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy[J]. Mol Cell Endocrinol, 2014, 392(1-2):163-172. [12] Wilflingseder J, Sunzenauer J, Toronyi E, et al. Molecular pathogenesis of post-transplant acute kidney injury:assessment of whole-genome mRNA and miRNA profiles[J]. PLoS One, 2014, 9(8):e104164. [13] Liu Z, Wang J, Guo C, et al. microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway[J]. Biomed Pharmacother, 2015, 69:24-28. [14] 涂容芳, 张秀峰, 何振华. 5-HTR2B、E-cad、α-SMA在博莱霉素致大鼠肺纤维化中的表达变化[J]. 中国应用生理学杂志, 2016, 32(4):365-369. [15] Haghikia A, Hilfiker-Kleiner D. MiRNA-21:a key to controlling the cardiac fibroblast compartment[J]. Cardiovasc Res, 2009, 82(1):1-3. [16] Zhang Z, Peng H, Chen J, et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice[J]. FEBS Lett, 2009, 583(12):2009-2014. |